Showing results (151-160 of 167) with videos related to
Sort By:
Pageof 17
Urology|July 25, 2022
Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC)Michaela A Dinan, Lauren E Wilson, Melissa A Greiner, et al.Journal of Endourology|October 21, 2020
Study to Enhance Understanding of Stent-Associated Symptoms: Rationale and Study DesignCharles D Scales, H Henry Lai, Alana C Desai, et al.BMC Urology|April 7, 2022
Quality of life impact and recovery after ureteroscopy and stent insertion: insights from daily surveys in STENTSJonathan D Harper, Alana C Desai, Jodi A Antonelli, et al.Lancet (London, England)|March 21, 2026
Prevention of urinary stones with hydration: a randomised clinical trial of an adherence interventionAlana C Desai, Naim M Maalouf, Jonathan D Harper, et al.JCO Clinical Cancer Informatics|March 26, 2025
Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast CancerTon Wang, Drew Neish, Samantha M Thomas, et al.Cancer Medicine|September 4, 2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinomaLisa P Spees, Stephanie B Wheeler, Bradford E Jackson, et al.Urology|May 6, 2023
Patients' Experiences With the Removal of a Ureteral Stent: Insights From In-depth Interviews With Participants in the USDRN STENTS Qualitative Cohort StudyCarrie Dombeck, Charles D Scales, Kevin McKenna, et al.Journal of Geriatric Oncology|February 7, 2022
Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinomaDeborah R Kaye, Lauren E Wilson, Melissa A Greiner, et al.The Journal of Urology|December 9, 2024
Development of Prediction Models for Severe Pain and Urinary Symptoms After Ureteroscopy With Ureteral Stent Placement: Results From the STENTS Study and Initial Validation of Pain InterferenceGregory E Tasian, Jonathan D Harper, Hussein R Al-Khalidi, et al.Clinical Genitourinary Cancer|May 20, 2022
Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer AgentsLisa P Spees, Michaela A Dinan, Bradford E Jackson, et al.Pageof 17